CERENOME, INC. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
CERENOME, INC. (CNSY) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$8.24 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2021-02-22
- CERENOME, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2020-12-31 was -$3.59M, a 489.89% decline year-over-year.
- CERENOME, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2020-09-30 was -$1.73M, a 428.52% decline year-over-year.
- CERENOME, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2020-06-30 was -$1.84M.
- CERENOME, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2020-03-31 was -$1.09M.
- CERENOME, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2020 was -$8.24M.
- CERENOME, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2019 was -$3.28M.
- CERENOME, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2018 was -$8.88M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$3.59M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | -$5.32M derived: sum of 2 quarters · filed 2021-02-22 | -$7.15M derived: sum of 3 quarters · filed 2021-02-22 | -$8.24M 10-K · filed 2021-02-22 |
| 2020-09-30 | -$1.73M 10-Q · filed 2020-10-22 | -$3.57M derived: sum of 2 quarters · filed 2020-10-22 | -$4.65M 10-Q · filed 2020-10-22 | -$3.73M derived: sum of 4 quarters · filed 2021-02-22 |
| 2020-06-30 | -$1.84M 10-Q · filed 2020-08-10 | -$2.93M 10-Q · filed 2020-08-10 | -$2.01M derived: sum of 3 quarters · filed 2021-02-22 | -$1.48M derived: sum of 4 quarters · filed 2021-02-22 |
| 2020-03-31 | -$1.09M 10-Q · filed 2020-05-14 | -$167.00K derived: sum of 2 quarters · filed 2021-02-22 | $359.00K derived: sum of 3 quarters · filed 2021-02-22 | -$1.91M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-12-31 | $920.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $1.45M derived: sum of 2 quarters · filed 2021-02-22 | -$821.00K derived: sum of 3 quarters · filed 2021-02-22 | -$3.28M 10-K · filed 2021-02-22 |
| 2019-09-30 | $526.00K 10-Q · filed 2020-10-22 | -$1.74M derived: sum of 2 quarters · filed 2020-10-22 | -$4.20M 10-Q · filed 2020-10-22 | -$6.21M derived: sum of 4 quarters · filed 2020-10-22 |
| 2019-06-30 | -$2.27M 10-Q · filed 2020-08-10 | -$4.73M 10-Q · filed 2020-08-10 | -$6.74M derived: sum of 3 quarters · filed 2020-08-10 | -$8.14M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | -$2.46M 10-Q · filed 2020-05-14 | -$4.47M derived: sum of 2 quarters · filed 2020-05-14 | -$5.87M derived: sum of 3 quarters · filed 2020-05-14 | -$8.15M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | -$2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$3.41M derived: sum of 2 quarters · filed 2020-03-30 | -$5.69M derived: sum of 3 quarters · filed 2020-03-30 | -$8.88M 10-K · filed 2020-03-30 |
| 2018-09-30 | -$1.40M 10-Q · filed 2019-11-14 | -$3.68M derived: sum of 2 quarters · filed 2019-11-14 | -$6.87M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | -$2.29M 10-Q · filed 2019-08-15 | -$5.47M 10-Q · filed 2019-08-15 | ||
| 2018-03-31 | -$3.28M 8-K · filed 2019-09-10 | |||
| 2017-12-31 | -$13.09M 8-K · filed 2019-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |